Tuesday, 12 June 2018

FibroGen Presents Clinical Results of Pamrevlumab Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer at ASCO 2018 Annual Meeting

#Track 18 : Laparoscopic Pancreatic Surgery

# P.S : https://bit.ly/2mIEceL



#Pancreatic surgery is still associated with a relatively high morbidity and mortality compared with other specialties. #Laparoscopic surgery is typically performed using 3 or 4 half-inch or one-inch incisions, sparing patients a large incision. Laparoscopic surgery is ideal for tumors of the #pancreas tail. Larger #tumors of any part of the pancreas for which an open operation is required can be started #laparoscopically to look for cancer spread before making the large incision. The hand-access devices are a major advancement in laparoscopic surgery and allows the #surgeon to place the hand into the abdomen during the surgical procedure. Patient who undergo laparoscopic #distal pancreatectomy have less pain, rapid recovery and early discharge compared to open distal #pancreatectomy.


FibroGen Presents Clinical Results of Pamrevlumab Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer at ASCO 2018 Annual Meeting: Demonstrates Enhanced Rate of Surgical Resection with Pamrevlumab in Patients with Previously Unresectable Disease

No comments:

Post a Comment

Clinical Gastro 2018!! Hepatocellular carcinoma Hepatocellular carcinoma  ( HCC ) is the most common type of primary liver cancer i...